Abhishek Chauhan

Dr. Abhishek Chauhan

Amity Institute of Environmental Science, Amity University, New Delhi, India
orcid

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 February 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
Gautam SethiGautam Sethi
Gautam Sethi
PRPrangya Rath
Prangya Rath
Abhishek ChauhanAbhishek Chauhan
Abhishek Chauhan
Anuj RanjanAnuj Ranjan
Anuj Ranjan
RCRenuka Choudhary
Renuka Choudhary
HTHardeep Singh Tuli
Hardeep Singh Tuli
Due to rising incidence rates of liver cancer and worries about the toxicity of current chemotherapeutic medicines, the hunt for further alternative methods to treat this malignancy has escalated. Compared to chemotherapy, quercetin, a flavonoid, is relatively less harmful to normal cells and is regarded as an excellent free-radical scavenger. Apoptotic cell death of cancer cells caused by quercetin has been demonstrated by many prior studies. It is present in many fruits, vegetables, and herbs. Quercetin targets apoptosis, by upregulating Bax, caspase-3, and p21 while downregulating Akt, PLK-1, cyclin-B1, cyclin-A, CDC-2, CDK-2, and Bcl-2. Additionally, it has been reported to increase STAT3 protein degradation in liver cancer cells while decreasing STAT3 activation. Quercetin has a potential future in chemoprevention, based on substantial research on its anticancer effects. The current review discusses quercetin’s mechanisms of action, nanodelivery strategies, and other potential cellular effects in liver cancer.

31 October 2022 in Cancers
Verified
Journal Article
Open access
PDF file
HTHardeep Singh Tuli
Hardeep Singh Tuli
PRPrangya Rath
Prangya Rath
Abhishek ChauhanAbhishek Chauhan
Abhishek Chauhan
Katrin SakKatrin Sak
Katrin Sak
DADiwakar Aggarwal
Diwakar Aggarwal
Shafiul HaqueShafiul Haque
Shafiul Haque
Increasing rates of cancer incidence and the toxicity concerns of existing chemotherapeutic agents have intensified the research to explore more alternative routes to combat tumor. Luteolin, a flavone found in numerous fruits, vegetables, and herbs, has exhibited a number of biological activities, such as anticancer and anti-inflammatory. Luteolin inhibits tumor growth by targeting cellular processes such as apoptosis, cell-cycle progression, angiogenesis and migration. Mechanistically, luteolin causes cell death by downregulating Akt, PLK-1, cyclin-B1, cyclin-A, CDC-2, CDK-2, Bcl-2, and Bcl-xL, while upregulating BAX, caspase-3, and p21. It has also been reported to inhibit STAT3 signaling by the suppression of STAT3 activation and enhanced STAT3 protein degradation in various cancer cells. Therefore, extensive studies on the anticancer properties of luteolin reveal its promising role in chemoprevention. The present review describes all the possible cellular interactions of luteolin in cancer, along with its synergistic mode of action and nanodelivery insight.

18 March 2025 in Current Research in Pharmacology and Drug Discovery
Verified
Journal Article
Open access
DADiwakar Aggarwal
Diwakar Aggarwal
MCMayank Chaudhary
Mayank Chaudhary
SMSachin Kumar Mandotra
Sachin Kumar Mandotra
HTHardeep Singh Tuli
Hardeep Singh Tuli
RCRitu Chauhan
Ritu Chauhan
Abhishek ChauhanAbhishek Chauhan
Abhishek Chauhan
Flavonoids are hydroxylated polyphenols that are abundantly produced by plants as secondary metabolites. These flavonoids hold vast therapeutic potential as they possess numerous medicinal benefits encompassing anti-inflammatory, anti-oxidative, anticancer and antiviral properties. Flavonoids render anti-inflammatory effect either by activating antioxidant pathways or by inhibiting enzymatic secretions involved in inflammatory reactions. Flavonoids like quercetin targets inflammation by modulating expression of cytokines and pro-inflammatory molecules and by inhibiting pro-inflammatory enzymes. Mode of action, absorption and bioavailability of flavonoids greatly affect their biological activity. On-going research is focussing on isolation, synthesis of flavonoid analogs and effect of flavonoids on human health by manifestation of different techniques and animal models. Unravelling the anti-inflammatory potential of flavonoids can manifest better treatment options against variety of diseases and metabolic syndromes. Additionally, enhanced bioavailability of flavonoids can result in superior pharmaceutical activities.

12 December 2022 in Molecules
Verified
Journal Article
Open access
PDF file
HTHardeep Singh Tuli
Hardeep Singh Tuli
PRPrangya Rath
Prangya Rath
Abhishek ChauhanAbhishek Chauhan
Abhishek Chauhan
SRSeema Ramniwas
Seema Ramniwas
KVKanupriya Vashishth
Kanupriya Vashishth
Katrin SakKatrin Sak
Katrin Sak
Phloretin is a natural dihydrochalcone found in many fruits and vegetables, especially in apple tree leaves and the Manchurian apricots, exhibiting several therapeutic properties, such as antioxidant, antidiabetic, anti-inflammatory, and antitumor activities. In this review article, the diverse aspects of the anticancer potential of phloretin are addressed, presenting its antiproliferative, proapoptotic, antimetastatic, and antiangiogenic activities in many different preclinical cancer models. The fact that phloretin is a planar lipophilic polyphenol and, thus, a membrane-disrupting Pan-Assay Interference compound (PAIN) compromises the validity of the cell-based anticancer activities. Phloretin significantly reduces membrane dipole potential and, therefore, is expected to be able to activate a number of cellular signaling pathways in a non-specific way. In this way, the effects of this minor flavonoid on Bax and Bcl-2 proteins, caspases and MMPs, cytokines, and inflammatory enzymes are all analyzed in the current review. Moreover, besides the anticancer activities exerted by phloretin alone, its co-effects with conventional anticancer drugs are also under discussion. Therefore, this review presents a thorough overview of the preclinical anticancer potential of phloretin, allowing one to take the next steps in the development of novel drug candidates and move on to clinical trials.

10 November 2023 in Molecules
Verified
Journal Article
Open access
PDF file
HJHemant Joshi
Hemant Joshi
HTHardeep Singh Tuli
Hardeep Singh Tuli
Anuj RanjanAnuj Ranjan
Anuj Ranjan
Abhishek ChauhanAbhishek Chauhan
Abhishek Chauhan
Shafiul HaqueShafiul Haque
Shafiul Haque
DKDivya Kandari
Divya Kandari
Flavopiridol is a flavone synthesized from the natural product rohitukine, which is derived from an Indian medicinal plant, namely Dysoxylum binectariferum Hiern. A deeper understanding of the biological mechanisms by which such molecules act may allow scientists to develop effective therapeutic strategies against a variety of life-threatening diseases, such as cancer, viruses, fungal infections, parasites, and neurodegenerative diseases. Mechanistic insight of flavopiridol reveals its potential for kinase inhibitory activity of CDKs (cyclin-dependent kinases) and other kinases, leading to the inhibition of various processes, including cell cycle progression, apoptosis, tumor proliferation, angiogenesis, tumor metastasis, and the inflammation process. The synthetic derivatives of flavopiridol have overcome a few demerits of its parent compound. Moreover, these derivatives have much improved CDK-inhibitory activity and therapeutic abilities for treating severe human diseases. It appears that flavopiridol has potential as a candidate for the formulation of an integrated strategy to combat and alleviate human diseases. This review article aims to unravel the potential therapeutic effectiveness of flavopiridol and its possible mechanism of action.

28 March 2023 in Sustainability
Verified
Journal Article
Open access
PDF file
ARArathi Radhakrishnan
Arathi Radhakrishnan
BPBalaganesh P
Balaganesh P
VMVASUDEVAN MANGOTTIRI
VASUDEVAN MANGOTTIRI
NNN Natarajan
N Natarajan
Abhishek ChauhanAbhishek Chauhan
Abhishek Chauhan
RSRajpal Srivastav
Rajpal Srivastav
The increasing population density and industrialization are adversely affecting the environment globally. The contamination of the soil, agricultural lands, and water bodies with petroleum wastes and other hydrocarbon pollutants has become a serious environmental concern as perceived by the impacts on the aquatic and marine ecosystem. Various investigations have provided novel insights into the significant roles of microbial activities in the cleanup of hydrocarbon contaminants. However, the burden of these pollutants is expected to increase many folds in the next decade. Therefore, it is necessary to investigate and develop low-cost technologies rapidly, focusing on eco-sustainable development. An understanding of the details of biodegradation mechanisms paves the way for enhancing the efficiency of bioremediation technology. The current article reviews the applicability of various bioremediation processes, biodegradation pathways, and treatments, and the role of microbial activities in achieving efficient eco-sustainable bioremediation of hydrocarbon pollutants. It is envisaged that an integrated bioremediation approach, including biostimulation and bioaugmentation is preferably advocated for the cost-effective removal of toxic petroleum hydrocarbons and their derivatives.